These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 15985216

  • 1. Endostatin competes with bFGF for binding to heparin-like glycosaminoglycans.
    Reis RC, Schuppan D, Barreto AC, Bauer M, Bork JP, Hassler G, Coelho-Sampaio T.
    Biochem Biophys Res Commun; 2005 Aug 05; 333(3):976-83. PubMed ID: 15985216
    [Abstract] [Full Text] [Related]

  • 2. The minimal active domain of endostatin is a heparin-binding motif that mediates inhibition of tumor vascularization.
    Olsson AK, Johansson I, Akerud H, Einarsson B, Christofferson R, Sasaki T, Timpl R, Claesson-Welsh L.
    Cancer Res; 2004 Dec 15; 64(24):9012-7. PubMed ID: 15604266
    [Abstract] [Full Text] [Related]

  • 3. Sulfated malto-oligosaccharides bind to basic FGF, inhibit endothelial cell proliferation, and disrupt endothelial cell tube formation.
    Foxall C, Wei Z, Schaefer ME, Casabonne M, Fugedi P, Peto C, Castellot JJ, Brandley BK.
    J Cell Physiol; 1996 Sep 15; 168(3):657-67. PubMed ID: 8816920
    [Abstract] [Full Text] [Related]

  • 4. Inhibitory effects of a bacteria-derived sulfated polysaccharide against basic fibroblast growth factor-induced endothelial cell growth and chemotaxis.
    Nakayama Y, Iwahana M, Sakamoto N, Tanaka NG, Osada Y.
    J Cell Physiol; 1993 Jan 15; 154(1):1-6. PubMed ID: 8419396
    [Abstract] [Full Text] [Related]

  • 5. Endothelial proteoglycans inhibit bFGF binding and mitogenesis.
    Forsten KE, Courant NA, Nugent MA.
    J Cell Physiol; 1997 Aug 15; 172(2):209-20. PubMed ID: 9258342
    [Abstract] [Full Text] [Related]

  • 6. Endostatin variations in childhood acute lymphoblastic leukaemia--comparison with basic fibroblast growth factor and vascular endothelial growth factor.
    Schneider P, Vasse M, Corbière C, Legrand E, Marie-Cardine A, Boquet C, Cazin L, Vannier JP.
    Leuk Res; 2007 May 15; 31(5):629-38. PubMed ID: 17011029
    [Abstract] [Full Text] [Related]

  • 7. The 140-kilodalton antiangiogenic fragment of thrombospondin-1 binds to basic fibroblast growth factor.
    Taraboletti G, Belotti D, Borsotti P, Vergani V, Rusnati M, Presta M, Giavazzi R.
    Cell Growth Differ; 1997 Apr 15; 8(4):471-9. PubMed ID: 9101093
    [Abstract] [Full Text] [Related]

  • 8. Capillary electrophoresis and enzyme solid phase assay for examining the purity of a synthetic heparin proteoglycan-like conjugate and identifying binding to basic fibroblast growth factor.
    Dimitrellos V, Lamari FN, Militsopoulou M, Kanakis I, Karamanos NK.
    Biomed Chromatogr; 2003 Jan 15; 17(1):42-7. PubMed ID: 12583005
    [Abstract] [Full Text] [Related]

  • 9. Involvement of MAPKs in endostatin-mediated regulation of blood-retinal barrier function.
    Campbell M, Collery R, McEvoy A, Gardiner TA, Stitt AW, Brankin B.
    Curr Eye Res; 2006 Dec 15; 31(12):1033-45. PubMed ID: 17169842
    [Abstract] [Full Text] [Related]

  • 10. Internalization of basic fibroblast growth factor (bFGF) in cultured endothelial cells: role of the low affinity heparin-like bFGF receptors.
    Rusnati M, Urbinati C, Presta M.
    J Cell Physiol; 1993 Jan 15; 154(1):152-61. PubMed ID: 8419401
    [Abstract] [Full Text] [Related]

  • 11. Bovine lactoferricin inhibits basic fibroblast growth factor- and vascular endothelial growth factor165-induced angiogenesis by competing for heparin-like binding sites on endothelial cells.
    Mader JS, Smyth D, Marshall J, Hoskin DW.
    Am J Pathol; 2006 Nov 15; 169(5):1753-66. PubMed ID: 17071598
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Early increase in serum levels of the angiogenesis-inhibitor endostatin and of basic fibroblast growth factor in melanoma patients during disease progression.
    Kurschat P, Eming S, Nashan D, Krieg T, Mauch C.
    Br J Dermatol; 2007 Apr 15; 156(4):653-8. PubMed ID: 17263813
    [Abstract] [Full Text] [Related]

  • 14. The inhibitory effects of endostatin on endothelial cells are modulated by extracellular matrix.
    Delaney CE, Weagant BT, Addison CL.
    Exp Cell Res; 2006 Aug 01; 312(13):2476-89. PubMed ID: 16725139
    [Abstract] [Full Text] [Related]

  • 15. Impact of endostatin on bFGF-induced proliferation, migration, and matrix metalloproteinase-2 expression/secretion of bovine choroidal endothelial cells.
    Wang YS, Eichler W, Friedrichs U, Yafai Y, Hoffmann S, Yasukawa T, Hui YN, Wiedemann P.
    Curr Eye Res; 2005 Jun 01; 30(6):479-89. PubMed ID: 16020281
    [Abstract] [Full Text] [Related]

  • 16. HSulf-1 inhibits angiogenesis and tumorigenesis in vivo.
    Narita K, Staub J, Chien J, Meyer K, Bauer M, Friedl A, Ramakrishnan S, Shridhar V.
    Cancer Res; 2006 Jun 15; 66(12):6025-32. PubMed ID: 16778174
    [Abstract] [Full Text] [Related]

  • 17. The heparin binding motif of endostatin mediates its interaction with receptor nucleolin.
    Fu Y, Chen Y, Luo X, Liang Y, Shi H, Gao L, Zhan S, Zhou D, Luo Y.
    Biochemistry; 2009 Dec 15; 48(49):11655-63. PubMed ID: 19877579
    [Abstract] [Full Text] [Related]

  • 18. Vascular endothelial growth factor receptor-2 and low affinity VEGF binding sites on human glomerular endothelial cells: Biological effects and advanced glycosilation end products modulation.
    Pala L, Cresci B, Manuelli C, Maggi E, Yamaguchi YF, Cappugi P, Rotella CM, Giannini S.
    Microvasc Res; 2005 Nov 15; 70(3):179-88. PubMed ID: 16271941
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of bFGF/EGF-dependent endothelial cell proliferation by the hyaluronan-binding protease from human plasma.
    Etscheid M, Beer N, Kress JA, Seitz R, Dodt J.
    Eur J Cell Biol; 2004 Jan 15; 82(12):597-604. PubMed ID: 15035435
    [Abstract] [Full Text] [Related]

  • 20. Endostatin's heparan sulfate-binding site is essential for inhibition of angiogenesis and enhances in situ binding to capillary-like structures in bone explants.
    Gaetzner S, Deckers MM, Stahl S, Löwik C, Olsen BR, Felbor U.
    Matrix Biol; 2005 Jan 15; 23(8):557-61. PubMed ID: 15694132
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.